GSK to choose among U.K. plant sites by summer; Sanofi nabs FDA nod for head-lice lotion;

@FiercePharma: Can you imagine what Sanofi would look like now if it hadn't bought Genzyme? | Follow @FiercePharma

> GlaxoSmithKline ($GSK) says it will decide by summer among three rival sites for its new biopharmaceutical plant in the U.K. Article

> Sanofi ($SNY) won FDA approval for a new head-lice lotion, Sklice, based on the commonly used oral parasite fighter ivermectin. News

> Pfizer's ($PFE) agreement to sell its Indian animal health business to a different division is a procedural step toward hiving off its entire animal health division as planned. Report

> Reckitt Benckiser is aiming for emerging markets with its consumer health brands, restructuring the company to merge U.S. and European operations and cut costs there, while investing in faster-growing developing nations. Story

> The worldwide market for osteoporosis treatments is expected to hit $11.4 billion by 2015, a new market research report says, with $2.5 billion of the total in China. Article

> Hospira ($HSP) tapped Richard Davies as SVP and chief commercial officer, reporting to CEO F. Michael Ball. News

> CVS Caremark won a temporary restraining order that will allow it to continue selling controlled substances at two Florida pharmacies raided by the Drug Enforcement Administration. More

Biotech News

@FierceBiotech: The 25 most influential people in biopharma today. Report | Follow @FierceBiotech

@JohnCFierce: Viehbacher: "2012 has been marked red in my diary for years." More | Follow @JohnCFierce

@FierceMedDev: Merit Medical discloses warning letter regarding Merit Laureate hydrophilic guidewire. Release | Follow @FierceMedDev

> FDA rewards Roche with priority review for blockbuster cancer drug. News

> Sanofi touts R&D hopefuls as tonic for plunging profits. Story

> Illumina urges investors to shun $5.7B Roche bid. News

> Novartis vaccine Bexsero combats meningitis. Item

Drug Delivery News

> DexCom, Tandem Diabetes pursue combined CGM/insulin pump. Story

> OptiNose testing nose-to-brain delivery tech with migraine drug. More

> Report: China ramping up for global drug delivery tech battle. Article

> GW's cannabis-based mouth spray gains Austrian OK for MS spasms. News

Medical Device News

> Zimmer, ISTO start Phase III study of DeNovo tissue graft. Item

> Siemens teams up with ViiV, Tocagen on companion Dx. Article

> FDA advocates for device 'bar code' in face of OMB delay. More

> Velomedix scores $10.2M in Series B, taps new CEO. News

> Merit, PhotoMedex recipients of FDA warning letters. Piece

Biomarkers News

> Gene signature predicts cancer outcomes. More

> Heart attack? No, it's just a spinning class. Story

> Alzheimer's marker is seen in middle age. Article

> Personalized medicine grows in China with Chinese/Canadian collaboration. News

> Urine biomarker spots aggressive prostate cancer. More

And Finally... Researchers found links between genes associated with inflammation and the risk of ovarian cancer. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.